Tools
Stock profile

National Vision Holdings, Inc. (EYE)

EYE · Latest close $17.60 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$17.60
As of Nov 18, 2026
Tracked funds holding
1 of 149
2026 Q2 13F filings
Opened / added
0 / 1
vs previous quarter
Trimmed / exited
0
vs previous quarter

National Vision Holdings, Inc. (EYE) is held by 1 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding versus the previous quarter. Latest close $17.60 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Fundamentals
Revenue · FY2026
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

First Eagle Investment Management — 1 tracked fund hold EYE. See all holders.

Insider and Congress activity

No insider open-market activity or Congress trades reported for this stock in the recent window. Insider trading · Politician trading.

Often held alongside

ALCON INC (ALC) · COOPER COMPANIES, INC. (COO) · Warby Parker Inc. (WRBY) · Bausch & Lomb Corp (BLCO) · THERMO FISHER SCIENTIFIC INC. (TMO) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
First Eagle Investment Management0.01%429,618ADDED (+93.9%) Q3 filed Nov 10

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: -8.0% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

29.469.332024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding233 of 8,857 filers
Long-only filers among them231
Change vs 2026 Q1-15 net · 229 entered · 244 exited
Shares reported, all filers99,478,888
Reported value, all filers$1.9B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNasdaq
IndustryOphthalmic Goods (SIC 3851)
Revenue · FY2026$2.0B
Net income · FY2026$29.6M
Total assets · FY2026$2.0B
Shares outstanding79,069,313
Market cap (at latest close)$1.4B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 31, 2026.

Short interest

Shares short · Oct 15, 202615,740,393
Share of shares outstanding19.91%
Days to cover9.68

Shares short at recent settlements — Jul 31, 2026: 14.3M · Aug 14, 2026: 14.1M · Aug 31, 2026: 14.1M · Sep 15, 2026: 15.7M · Sep 30, 2026: 15.5M · Oct 15, 2026: 15.7M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 31, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 201 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 31, 2026.

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Mar 11, 2026Wilkes AlexanderOfficer, Director35,000$955.5KMar 11, 2026SEC filing
Mar 6, 2026FAHS L READEMember of immediate family of any of the foregoing4,071$120.4KMar 6, 2026SEC filing
Mar 6, 2026FAHS L READEOfficer, Director7,601$224.9KMar 6, 2026SEC filing
Sep 16, 2025FAHS L READEOfficer, Director10,598$253.6KSep 16, 2025SEC filing
Sep 15, 2025FAHS L READEOfficer, Director2,002$47.7KSep 15, 2025SEC filing
Aug 28, 2025FAHS L READEOfficer, Director137,400$3.3MAug 28, 2025SEC filing
May 16, 2025Moore Patrick R.Former Officer15,983$305.8KMay 16, 2025SEC filing
May 15, 2025Molony MeganOfficer10,581$196.8KMay 15, 2025SEC filing
May 14, 2025Molony MeganOfficer3,900$73.7KMay 14, 2025SEC filing
May 13, 2025Acharya RaviOfficer12,000$225.1KMay 13, 2025SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Aug 13, 2026Wellington Management Group LLPSC 13G/A7,669,8539.6%Jun 30, 2026SEC filing
Aug 6, 2026Wellington Management Group LLPSC 13G/A8,338,92710.4%Jul 31, 2026SEC filing
Aug 6, 2026FMR LLCSC 13G4,070,391.745.1%Jun 30, 2026SEC filing
Jul 31, 2026Vanguard Capital ManagementSC 13G/A3,994,6865.0%Jun 30, 2026SEC filing
Apr 30, 2026Vanguard Capital ManagementSC 13G4,020,1425.1%Mar 31, 2026SEC filing
Apr 29, 2026Vanguard Portfolio ManagementSC 13G5,781,7977.3%Mar 31, 2026SEC filing
Mar 27, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Feb 13, 2026American Century Investment Management, Inc.SC 13G/A3,580,3674.5%Dec 31, 2025SEC filing
Feb 10, 2026Wellington Management Group LLPSC 13G/A5,783,6997.3%Dec 31, 2025SEC filing
Nov 14, 2025Fund 1 Investments, LLCSC 13G/A358,8000.5%Sep 30, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Ophthalmic Goods (SIC 3851). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: 214 Lobbying Disclosure Act filings named this company as client, 2000–2026; most common issues: Health Issues (113), Budget/Appropriations (103), Medical/Disease Research/Clinical Labs (69).

Federal contracts: no obligated amounts found for this ticker (USASpending, fiscal years 2021–2026).

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Financial Screens

· Cash Flow (FCF) — Positive free cash flow in each of the last 3 years, with an FCF yield of at least 5%

Key figures

· Cash Flow (FCF) — Latest FCF: $73.5M · FCF yield: 5.5% · Positive FCF years: 3

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Insider BEST — appeared in 3 of the last 20 quarterly lists; latest 2024 Q2, ranked #38 of 50.

Also held by the tracked funds that hold EYE — ranked by lift, the co-holding pattern described in Methodology: ALCON INC (ALC) · COOPER COMPANIES, INC. (COO) · Warby Parker Inc. (WRBY) · Bausch & Lomb Corp (BLCO) · THERMO FISHER SCIENTIFIC INC. (TMO) · INTUITIVE SURGICAL INC (ISRG) · Medtronic plc (MDT) · WATERS CORP /DE/ (WAT).

8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Nov 12, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Aug 12, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Jun 22, 20265.07 Submission of Matters to a Vote of Security Holders · 9.01 Financial Statements and ExhibitsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

ALCON INC (ALC) · Track Record: how the signals scored · Practice timing on EYE

One email a week: the week’s new filings and research. Subscribe free

← EXTR  ·  EYPT →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.